Michelle Renee Griffin - Jun 17, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Michelle Griffin by Eric Billings, attorney-in-fact
Stock symbol
ADPT
Transactions as of
Jun 17, 2021
Transactions value $
-$128,800
Form type
4
Date filed
6/21/2021, 08:00 PM
Previous filing
Jun 16, 2021
Next filing
Jul 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $31.2K +4K +265.96% $7.80 5.5K Jun 17, 2021 Direct F1
transaction ADPT Common Stock Sale -$160K -4K -72.67% $40.00* 1.5K Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -4K -5.44% $0.00 69.5K Jun 17, 2021 Common Stock 4K $7.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
F2 The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.